Rating History for Salix Pharmaceuticals (SLXP) by Cantor Fitzgerald
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/24/2015 | N/A | Downgrade | Neutral (Overweight) |
N/A (N/A) |
155.76 (172.81) |
10.95% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/24/2015 | N/A | Downgrade | Neutral (Overweight) |
N/A (N/A) |
155.76 (172.81) |
10.95% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||